Skip to content
8-K

Material Event

ARTELO BIOSCIENCES, INC. ARTL

0001640334-26-000461

← back to feed
Filed
Mar 17, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted 2025 · Dec 31, 2025 343K sh
Shares Diluted restated 2024 · Dec 31, 2024 179K sh
Operating Cash Flow 2025 · Dec 31, 2025 −$8.52M
Operating Cash Flow 2024 · Dec 31, 2024 −$8.35M
Cash And Equivalents 2025 · Dec 31, 2025 $600K
Stockholders Equity 2025 · Dec 31, 2025 −$1.27M
Stockholders Equity 2024 · Dec 31, 2024 $2.86M
Stockholders Equity 2023 · Dec 31, 2023 $11.75M
Current Liabilities 2025 · Dec 31, 2025 $4.04M
Current Liabilities 2024 · Dec 31, 2024 $1.77M
Total Liabilities 2025 · Dec 31, 2025 $4.07M
Total Liabilities 2024 · Dec 31, 2024 $1.84M
Current Assets 2025 · Dec 31, 2025 $695K
Current Assets 2024 · Dec 31, 2024 $2.56M
Total Assets 2025 · Dec 31, 2025 $2.8M
Total Assets 2024 · Dec 31, 2024 $4.7M
Eps Diluted 2025 · Dec 31, 2025 −$37.75
Eps Diluted restated 2024 · Dec 31, 2024 −$54.89
Sga Expense 2025 · Dec 31, 2025 $5.98M
Sga Expense 2024 · Dec 31, 2024 $4.12M
Rd Expense 2025 · Dec 31, 2025 $5.42M
Rd Expense 2024 · Dec 31, 2024 $5.99M
Net Income 2025 · Dec 31, 2025 −$12.88M
Net Income 2024 · Dec 31, 2024 −$9.83M
Operating Income 2025 · Dec 31, 2025 −$11.4M
Operating Income 2024 · Dec 31, 2024 −$10.11M